公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | Decreased Colorectal Adenoma Risk after Helicobacter pylori Eradication: A Retrospective Cohort Study | Hu K.-C.; MING-SHIANG WU ; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu C.-C.; TUNG-HUNG SU ; WEI-CHIH LIAO ; CHI-LING CHEN ; CHUN-JEN LIU ; Shih S.-C. | Clinical Infectious Diseases | 15 | 14 | |
2009 | Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: A 20-year follow-up study | MEI-HWEI CHANG ; You S.-L.; Chen C.-J.; CHUN-JEN LIU ; Lee C.-M.; Lin S.-M.; Chu H.-C.; Wu T.-C.; Yang S.-S.; Kuo H.-S.; DING-SHINN CHEN | Journal of the National Cancer Institute | 494 | 408 | |
2019 | Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers | KAI-CHI CHANG ; MEI-HWEI CHANG ; CHIEN-NAN LEE ; Chang C.-H.; JIA-FENG WU ; YEN-HSUAN NI ; Wen W.-H.; MING-KWANG SHYU ; Lai M.-W.; Chen S.-M.; Hu J.-J.; Lin H.H.; Hsu J.-J.; Mu S.-C.; Lin Y.-C.; CHUN-JEN LIU ; DING-SHINN CHEN ; Lin L.-H.; HUEY-LING CHEN ; HSIAO-LIN HWA ; Su Y.-N.; JIN-CHUNG SHIH ; KUANG-HAN CHAO ; HONG-YUAN HSU ; YU-CHUN CHIU ; TUNG-HUNG SU ; Lin C.-C.; Lin P.-Y.; Yang W.-R.; Zhao L.-L.; Yang C.-K.; Chang Y.-K.; Chen K.-H.; Lin Y.-H.; Chen H.-J.; Pan H.-S.; Lau B.-H.; Lee C.-L.; Cheng P.-J.; Chang Y.-L.; Chiueh H.-Y.; Wang T.-H.; Lo L.-M.; Hsieh C.-L.; Cheng S.-W.; Tsai M.-S.; She B.-Q.; Koh K.-J.; Hung Y.-L.; Lin H.-M.; Peng F.-S.; Wu T.-C.; Chen C.-Y.; Chen C.-P.; Huang J.-P.; Yeung C.-Y.; Lin C.-J.; Chiu W.-T.; Wang D.-S.; Lin W.-T.; Hwang K.-S.; Huang C.-F.; The Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study) | Alimentary Pharmacology and Therapeutics | 19 | 18 | |
2012 | Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 129 | 115 | |
2015 | Development of risk scoring system for stratifying population for hepatocellular carcinoma screening | Hung Y.-C.; Lin C.-L.; CHUN-JEN LIU ; Hung Hung ; Lin S.-M.; Lee S.-D.; PEI-JER CHEN ; Chuang S.-C.; MING-WHEI YU | Hepatology | 38 | 39 | |
2012 | Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy | WANG-HUEI SHENG ; CHIEN-CHING HUNG ; SUI-YUAN CHANG ; CHUN-JEN LIU ; Chen M.-Y.; SZU-MIN HSIEH ; JIA-HORNG KAO ; PEI-JER CHEN ; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 13 | 12 | |
2010 | Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B | Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; CHUN-JEN LIU ; Lai M.-Y.; DING-SHINN CHEN ; Yang S.-S.; JIA-HORNG KAO | Antiviral Therapy | 39 | 38 | |
2020 | Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection | Cheng X.; Uchida T.; Xia Y.; Umarova R.; CHUN-JEN LIU ; PEI-JER CHEN ; Gaggar A.; Suri V.; Mücke M.M.; Vermehren J.; Zeuzem S.; Teraoka Y.; Osawa M.; Aikata H.; Tsuji K.; Mori N.; Hige S.; Karino Y.; Imamura M.; Chayama K.; Liang T.J. | Journal of Clinical Investigation | 40 | 36 | |
2006 | Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series | Huang Y.-W.; CHUN-JEN LIU ; Lai M.-Y.; PO-HUANG LEE ; MENG-KUN TSAI ; SHOEI-SHEN WANG ; Lai M.-K.; JIA-HORNG KAO | Clinical Therapeutics | 7 | 6 | |
2008 | Disease progression in a patient with nonalcoholic steatohepatitis | PING-HUEI TSENG ; CHUN-JEN LIU ; JIA-HORNG KAO ; CHIA-TUNG SHUN ; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 10 | 6 | |
2023 | Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B | SHANG-CHIN HUANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; Lan, Ting-Yuan; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology international | 5 | 2 | |
2013 | Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion | HUNG-CHIH YANG ; CHI-LING CHEN ; Shen Y.-C; Peng C.-Y; CHUN-JEN LIU ; TAI-CHUNG TSENG ; TUNG-HUNG SU ; Chuang W.-L; Yu M.-L; Dai C.-Y; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 43 | 37 | |
2018 | Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy | TUNG-HUNG SU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; JYH-MING LIOU ; CHEN-HUA LIU ; CHI-LING CHEN ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Journal of Infectious Diseases | 57 | 52 | |
2023 | Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease | Lin, Meng-Ju; TUNG-HUNG SU ; CHIEH-CHANG CHEN ; WEI-KAI WU ; SHIH-JER HSU ; TAI-CHUNG TSENG ; SIH-HAN LIAO ; CHUN-MING HONG ; HUNG-CHIH YANG ; CHUN-JEN LIU ; MING-SHIANG WU ; JIA-HORNG KAO | Gut pathogens | 2 | 2 | |
2021 | Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan | CHUN-MING HONG ; Lin, You-Yu; CHUN-JEN LIU ; Lai, Ya-Yun; Shiou-Hwei Yeh ; HUNG-CHIH YANG ; JIA-HORNG KAO ; SHIH-JER HSU ; Huang, Yi-Hsiang; Yang, Sheng-Shun; Kuo, Hsing-Tao; Cheng, Pin-Nan; Yu, Ming-Lung; PEI-JER CHEN | Viruses | 5 | 2 | |
2009 | Dual chronic hepatitis B virus and hepatitis C virus infection | CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology International | 43 | 37 | |
2007 | Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients | Wang C.-C.; CHUN-JEN LIU ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Liver International | 7 | 7 | |
2019 | Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 10 | 9 | |
2007 | Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan | Hsu C.-S.; CHUN-JEN LIU ; Lai M.-Y.; PEI-JER CHEN ; JIA-HORNG KAO ; DING-SHINN CHEN | Intervirology | 17 | 16 | |
2024 | Editorial: Tenofovir disoproxil fumarate more than an antiviral drug-Another piece of the puzzle. Authors' reply | Cheng, Pin-Nan; CHUN-JEN LIU | Alimentary pharmacology & therapeutics | 0 | 0 | |